We have located links that may give you full text access.
Journal Article
Review
Adeno-Associated Virus-mediated Gene Therapy for Cardiac Tachyarrhythmia: A Systematic Review and Meta-analysis.
Heart Rhythm : the Official Journal of the Heart Rhythm Society 2024 Februrary 8
Cardiac tachyarrhythmia presents a significant healthcare challenge, causing notable morbidity and mortality. Conventional treatments have limitations and potential risks, resulting in an elevated disease burden. Adeno-associated virus (AAV)-mediated gene therapy holds promise as a potential future treatment option. Therefore, we aim to provide a measured overview of the latest developments in this rapidly growing field. PubMed and Embase databases were searched up to January 2024. Studies that employed AAV as a vector for delivering therapeutic agents to treat cardiac tachyarrhythmia were included. Twenty-six studies were included with 20 of them published in the last five years. There were 22 novel molecular targets identified. More than 80% of the included studies employed small animal models or utilized AAV9. In atrial fibrillation (AF) pre-clinical studies, AAV-mediated gene therapy reduced AF inducibility by 81% (OR 0.19[0.08,0.45]; p<0.01). Similarly, for acquired and inherited ventricular arrhythmia (VA), gene therapy treated animal models had less inducible VA with OR 0.06[0.03,0.11]; p<0.01. This review highlights the rapid progress of AAV-mediated gene therapy in the treatment of cardiac tachyarrhythmia. While these investigations are currently in the early stages of clinical application, they present promising prospects for gene therapy. (PROSPERO registry: CRD42023479448).
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app